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Kinetic and mechanistic investigations have been made on the displacement of the two aqua molecules from the complex 
1 i.e., [Pt(2,2′-bipyridine)(H2O)2]
2+ represented as {Pt(bpy)} (bpy = 2,2′-bipyridine) at pH 4.0. All the substitution reactions 
have been monitored at 264, 284 & 317 nm, where the spectral difference between the reactant and product is maximum. 
Two consecutive reaction steps have been observed for the substitution of aqua molecules with some bidentate N,N-donor 
ligands namely, dimethylglyoxime (L1H), 1, 2-cyclohexanedionedioxime (L2H) and α-furildioxime (L3H) in ethanol-water 
medium using variable-temperature and stopped-flow spectrophotometry. Among the two steps, the former is ligand 
dependent and the later is ligand independent, where chelation is observed. All rate and activation parameters are consistent 
with associative substitution mechanisms. The thermodynamic parameters have been also calculated, which gives a negative 
G0 value at all temperatures studied, supporting the spontaneous formation of an outer sphere association complex. The 
products of the reaction have been characterized with the help of IR and ESI-MS spectroscopic analysis. 
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Cis-diamminedichloroplatinum(II) (cisplatin) has 
been established as the leading compound for the 
treatment of different types of cancer. It is highly 
effective in the treatment of testicular and ovarian 
cancers and is also employed for treating bladder, 
cervical, head and neck, oesophageal, and small cell 
lung cancer
1
. However, some tumors such as 
colorectal and non small cell lung cancers have 
intrinsic resistance to cisplatin, while others such as 
ovarian or small cell lung cancers develop acquired 
resistance after the initial treatment
2
. Biochemical 
studies have not clearly established the molecular 
bases of resistance to cisplatin in any type of cell, but, 
at least, they have identified several mechanisms that 
can contribute to this phenomenon. Resistance to 
cisplatin is generally multifactorial and has been 
shown to be due to reduced drug accumulation, 
inactivation by thiol containing species, increased 
repair/tolerance of platinum-DNA adducts, and 
alterations in proteins involved in apoptosis
3,4
. 
One strategy to overcome cisplatin resistance is to 
design platinum complexes that specifically deal with 
some or even all of the above-mentioned resistance 
mechanisms. Further studies in this field revealed a 
number of different Pt(II) complexes, structurally 
similar to cisplatin, with reduced toxicity, but still not 
suitable for longer application
5-7
.To date, about 3000 
different platinum complexes have been synthesized 
and investigated in an attempt to improve the 
antitumor activity, to lower the toxicity and to design 
a drug that is able to overcome cell resistance. 
However, only about 30 platinum complexes have 
hitherto entered clinical trials
8-10
. Moreover, only four 
platinum drugs namely; cisplatin, carboplatin, 
oxaliplatin and nedaplatin are currently registered for 
clinical use (marketed drugs)
11
. Among the registered 
platinum drugs, carboplatin, [cis-diammine-1,1′-
cyclobutanedicarboxylateplatinum(II)], is less toxic 
than cisplatin but possesses the same spectrum of 
antitumor activity. The only registered platinum drug 
that has consistently demonstrated antitumor activity 
against cisplatin resistant tumors such as colorectal 




However, there have been recently reported several 
novel classes of platinum complexes able to 
circumvent cisplatin resistance in preclinical or even 
clinical studies including cis-Pt(II) compounds with 
planar ligands, trans-Pt(II) and trans-Pt(IV) 
compounds, and polynuclear platinum complexes
13
. 




Taking into account the above-mentioned 
considerations, there is little doubt that the search for 
novel platinum compounds able to circumvent 
cisplatin resistance has proven to be a difficult task. 
The coordination compounds of vicinal dioximes 
have been widely investigated as analytical  
reagents
14
, models for biological systems such as 
vitamin B12
15
, compounds with columnar stacking 
thought to be behind their semiconducting properties
16
 
and recently effective new dioxygen carriers
17
. In this 
study, the reactions of Pt(bpy) with some bidentate  
N, N-donor ligands viz., dimethylglyoxime (L1H),  
1,2-cyclohexanedionedioxime (L2H) and  
α-furildioxime (L3H) were investigated by stopped-
flow spectrophotometry. 
 
Materials and Methods 
K2PtCl4, 2,2′-bipyridine and vicinal dioximes were 
purchased from Sigma-Aldrich Company. All other 
reagents were obtained from commercial sources and 
used without purification. All kinetics studies were 
performed in 10% ethanol-water (v/v) mixture. The 
complex [Pt(bpy)(H2O)2](ClO4)2 termed as complex 
1, was prepared in our previous paper according to the 
literature
18,23
. The pH of the solution was so 
maintained (pH = 4.0) that more than 90% of the 
perchlorate salt was obtained as diaqua species. The 
reaction products of complex 1 with the above three 
vicinal dioximes (LH) were prepared by mixing the 
reactants in different ratio’s namely 1:5, 1:10, 1:20 
and 1:30 and equilibrating the mixture at (30 ± 0.1) 
o
C 
for 48 h. The absorption spectra of all these mixtures 
for each individual ligand exhibited the same λmax 
with nearly identical intensities. The difference in 
spectra between the product complexes and the 
substrate complex is shown in Fig. 1. 
The pH measurements were carried out with the help 
of a Sartorius Digital pH meter (model PB11) with an 
accuracy of ±0.01 units. Infrared (IR) spectroscopy on 
KBr pellets was performed on a Shimadzu FT-IR model 
IR Prestige 21 infrared spectrophotometer from  
4,000 to 400 cm
-1
. ESI-MS were recorded using a 
micromass Q-ToF micro
TM
 mass spectrometer in 
positive ion mode. Electronic spectra (UV/visible) and 
kinetic measurements were monitored in a Hi-Tech 




The composition in the solution was determined by 
Job’s method of continuous variation. The 
metal:ligand ratio was found to be 1:1 (Fig. 2). When 
another two ligands react with the complex 1, this 
ratio is also observed. As indicated from Job’s 
method, complex 1 and the ligands were mixed in 1:1 
molar ratio at pH 4.0 heated at 60 
o
C for 72 h, then 
transferred in a glass beaker and slowly evaporated at 
room temperature and finally in a desiccators. The 
yellowish products obtained were used for IR and 
ESI-MS spectroscopic analysis. 
 
IR spectral analysis 
The IR spectrum of the product, complex 1 with 
that of L2H (in KBr disk) showed (Supplementary 
Data, Fig. S1) strong characteristic bands at  
 
 
Fig. 1 ― Spectra of the starting complex. [complex 1] = 3.7×10-5 
mol dm-3 (1), complex 1 + [α-furil dioxime] = 7.4×10-4 mol dm-3 
(2), complex 1 + [1, 2-cyclohexanedionedioxime] = 7.4×10-4 mol 
dm-3 (3) and the last one is complex 1 with that of 
[dimethylglyoxime] = 7.4×10-4 mol dm-3 (4) at pH = 4.0,  




Fig. 2 ― Job’s plot for the reaction of complex 1 with L2H at 
pH = 4.0 and ionic strength = 0.1 mol dm-3 NaClO4. 




3323 and 528 cm
-1
, respectively. The strong band at 
3323 cm
-1
 indicates that the product is hydrated or 
contained free -OH group. The stretching frequency at 
528 cm
-1
 is assigned to υ(Pt-N) bond in the product
19
. 
The absence of a strong band due to Pt-O bond at  
617 cm
-1 20
, present in starting complex 1 
(Supplementary Data, Fig. S2) suggests the absence 
of Pt–O bond in the product complex. So the IR 
spectrum strongly suggests that the final product is an 
N, N coordinated chelate and the  
1,2-cyclohexanedionedioxime behaves as a bidentate 
ligand in the experimental pH. 
 
Mass spectral analysis 
The ESI mass spectra of the products have shown 
in Supplementary Data, Figs. S3 & S4. It is clear from 
the first spectrum that the ion at m/z ~ 466 has 
become the molecular ion species in the solution 
mixture and this is attributed to 
[Pt(II)+bpy+dimethylglyoxime anion]. On the other 
hand, in the second spectrum the ion at m/z ~ 615 has 
become the molecular ion species in the solution 
mixture and this is attributed to [Pt(II)+bpy+1,2-
cyclohexanedionedioxime anion + NaClO4]. 
 
Kinetic measurements 
The kinetic measurements of these systems were 
monitored in a Hi-Tech stopped flow 
spectrophotometer (TGK Scientific, Bradford-on-
Avon, UK). The conventional mixing technique was 
followed and pseudo-first order conditions were 
employed throughout. The progress of the reaction 
was studied by following the development of peaks at 
264, 284 and 317 nm for L1H, L2H and L3H, 
respectively, where the differences in absorbance 
between the substrate and the product complexes are 
maximum. Origin software was used for 
computational analysis. Rate data, represented as an 
average of duplicate runs, were reproducible to within 
±4 %. The kinetic measurements of these systems 
were done as discussed in our previous work
18
. In this 
paper the nature of the two typical plots {ln(A∞-At) vs 
time and ln vs time} are also the same as discussed 




Results and Discussion 
The pKa values at 25 
o
C of the ligands L1H, L2H 
and L3H are given in Table 1. From the pKa values of 
all the ligands we can say that at pH 4.0, all these 
three ligands remain in the neutral form. On the other 
hand the pK1 & pK2 values for cis-[Pt(bpy)(H2O)2]
2+ 
have been evaluated by Irving-Rossotti technique
22
 
and found to be 4.80, 6.32, respectively at 25 
o
C. 
Hence it can be assumed that at pH 4.0, the reactant 
complex exists as diaqua ion. The reactions followed 
two-step consecutive process; the first step is 
dependent on ligand concentration whereas the 
second is independent of ligand concentration. In the 
first step one aqua ligand was replaced from complex 
1 by ligands. The second is a slower step, where 
another water molecule is substituted. This is the ring 
closure step. The rate constant for such a process can 
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where A is the diaqua species (complex 1), B is the 
single substituted intermediate, C is the final chelated 
product complex [Pt(bpy)(L)]
+
. Formation of C from 
B is predominant after some time has elapsed. 
 
Table 1 ― pKa values of three ligands named Dimethylglyoxime (L1H), 1, 2-Cyclohexane dionedioxime (L2H) & α –Furildioxime (L3H) at 25
oC 
Ligands Structures Reference 
Dimethylglyoxime 
(L1H) 

































Calculation of k1 for A → B step 
The rate constants for the first step of the reaction 
(A → B) were calculated from the absorbance data 
using the origin 6.0 software. The k1(obs) values for 
different concentrations of ligand at different 
temperatures are given in Table 2. The rate increases 
for the above complex with increases in [ligand] 
before reaching a limiting value (Figs. 3, S5 & S6), 
which is probably due to the completion of the outer-
sphere association complex formation through H-
bonding. Based on the experimental findings, the 
following scheme may be proposed: 
 
[Pt(bpy)(H2O)2]
2++ LH  
KE
⇌
   [Pt(bpy)(H2O)2]
2+…            …LH 
 






[Pt bpy  H2O  LH ]
2++ H2O  









where, LH is the neutral form of the above ligands. 
Based on the above scheme, a rate expression can be 




= k1KE A  LH                                               …(1) 
 
where A is the diaqua species (complex 1), B is the 
single substituted intermediate and LH is neutral ligand. 
KE= [associated A]  A [AH]   




= A +  associated A             
or, [A]
T
= A + KE A  LH     
or,  A = [A]
T
(1+  KE[LH])                                …(2)  











= k1(obs)[A]T; where T is total concentration of A. 




The equation can be represented as 
 
1 k1(obs)  = 1 k1 + 1 k1KE [LH]                          …(3) 
 
Depending upon the above final equation, we have 
drawn a figure of 1/k1(obs) versus 1/ [LH]. The plot is 
Table 2 ― 102 k1(obs) (s
-1) values for different concentrations of ligands at different temperatures; [cis-[Pt(bpy)(H2O)2)]
2+] = 1.85 × 10-4 
mol dm-3, pH = 4.0, ionic strength = 0.1 mol dm-3 NaClO4, in 10% ethanol-water (v/v) mixture 
 Ligand 
 
Temp. (oC ) 103 [ ligand ] (mol dm-3) 
1.85 2.78 3.70 4.63 5.55 
 
L1H 
40 7.32±0.01 10.15±0.03 12.42±0.02 14.70±0.04 15.62±0.03 
45 8.84±0.04 11.94±0.02 15.05±0.03 17.19±0.05 18.28±0.01 
50 10.64±0.03 14.63±0.02 17.99±0.01 20.74±0.04 21.13±0.03 
55 13.52±0.01 18.46±0.04 22.36±0.03 24.73±0.02 26.17±0.01 
 
L2H 
40 6.03±0.04 8.22±0.01 10.07±0.02 11.43±0.03 12.33±0.05 
45 7.54±0.02 10.29±0.03 12.30±0.04 13.81±0.01 15.20±0.05 
50 9.51±0.05 12.8±0.01 15.3±0.03 17.24±0.04 18.64±0.01 




40 4.77±0.04 6.48±0.01 7.82±0.03 9.07±0.04 10.31±0.01 
45 6.33±0.03 8.49±0.02 10.27±0.04 11.66±0.01 13.45±0.03 
50 7.66±0.05 10.18±0.04 12.43±0.03 13.95±0.02 15.79±0.01 
55 10.26±0.04 13.63±0.03 16.57±0.01 18.17±0.04 20.32±0.03 
 
 
Fig. 3 ― Plots of k1(obs)  (s
-1)  versus [L1H] (mol dm
-3) at different 
temperatures. A = 40 oC, B = 45 oC, C = 50 oC and D = 55 oC. 




linear with an intercept of 1/k1 and slope 1/k1KE. This 
was found to be so, at all temperatures studied  
(Figs. 4, S7 & S8). The values of k1 and KE were 
obtained from the intercept and slope to intercept ratio 
respectively, and are included in Table 3. 
 
Calculation of k2 for B→ C step 
The B → C step is assigned to ring closure where 
another nitrogen atom of those ligands binds the metal 
center. This chelation step is independent of ligand 
concentration. At each temperature, the k2 values were 
calculated from the limiting linear portion (when t is 
large) of the ln(A∞ – At) versus t curves and are 
collected in Table 3. 
 
Effect of pH on the reaction rate 
The reaction was studied at five different pH 









 [ligand] and 0.1 mol dm
-3
  
NaClO4 ionic strength, the 10
2
k1(obs) values were 7.25, 
8.91, 10.07, 11.51, 12.99 and 10
4
k2 values were 1.19, 
1.45, 1.81, 2.19, 2.61, respectively for complex 1 with 
that of L2H at pH 3.0, 3.5, 4.0, 4.5 and 5.0, 
respectively at 40 
o
C.  The change in rate may be 
explained based on two acid dissociation equilibria of 
the ligand and for the complex. Within our studied pH 
range the above ligands, remain unchanged so the 
effects of pH on rate are therefore due to the change 
in reactive forms of the reacting complex. 
 
Effect of substituents in the ligand frame 
If two methyl groups in L1H are successively 
replaced by cyclohexane ring in L2H and two furan 
rings in L3H, the substituent effect shows that there is 
a gradual decrease of rate constant values from L1H to 
L3H through L2H. For L1H, L2H and L3H, the relative 
λmax positions of LH substituted products are found to 
be 264, 284 & 317 nm, respectively (Fig. 1). It 
decides a clear evidence of weak donicity trend as a 
sharp lower energy shift of λmax position in going 
from complexed L1H to L3H through L2H. The 
measurement of rate constant values depends on both 
electronic and steric factors. For an associative 
activation with increase in the size of the incoming 
ligand, the activated state is crowded and as a result a 
decrease in rate with increased crowding is observed. 
This also supports a ligand assisted mechanism. 
 
Effects of temperature on reaction rate 
Those reactions were monitored at four different 
temperatures for diverse ligand concentrations and the 
substitution rate constants for both A → B (k1) and  
B → C (k2) steps are arranged in Table 3. The 
activation parameters calculated from Eyring plots 
(Figs. 5, S9 & S10) are tabulated in Table 4. 
 
Mechanism  
The interaction of dimethylglyoxime (L1H),  




Fig. 4 ― Plots of 1/k1(obs) (s) versus 1/ [L1H] (dm
3 mol-1)  
at different temperatures A = 40 oC, B = 45 oC, C = 50 oC and  
D = 55 oC for complex 1. 
Table 3 ― The k1, KE and k2 values for the substitution reaction between different ligands with complex 1 






40 39.59±0.03 123±0.02 2.51±0.01 
45 43.29±0.04 139±0.01 3.13±0.03 
50 48.58±0.01 153±0.03 4.06±0.02 
55 53.59±0.05 185±0.02 5.22±0.01 
 
L2H 
40 27.41±0.04 153±0.02 1.81±0.04 
45 31.34±0.01 172±0.03 2.39±0.03 
50 37.03±0.02 188±0.05 3.21±0.02 
55 42.14±0.03 214±0.04 4.44±0.01 
 
L3H 
40 23.40±0.02 138±0.01 1.17±0.04 
45 28.43±0.01 154±0.04 1.95±0.05 
50 32.47±0.05 166±0.02 2.98±0.01 
55 39.57±0.04 189±0.03 4.24±0.02 





dioxime (L3H) with the title platinum complex 








). First step proceeds via an associative 
interchange activation and the second step is the ring 
closure. At the outset of first step outer sphere 
association complex results, this is stabilized through 
H-bonding and is followed by an interchange from the 
outer sphere to the inner sphere complex. The outer 
sphere association equilibrium constants, a measure of 
the extent of H-bonding at different temperatures are 
evaluated (Table 3). A typical plot of lnKE vs 1/T for 
complex 1 with L2H is drawn in supplementary data, 





) were also 
calculated (Supplementary Data, Table S1),  
which gives a negative G
0
 value at all  
temperatures studied, supporting the spontaneous 
formation of an outer sphere association complex  
in the first step. 
 
 
Fig. 5 ― Eyring plot of ln(k1h/kBT) versus 1/T for the step A → B 
(For complex 1 with  L1H). 
 
 
Fig. 6 ― Plausible mechanism for the substitution of aqua ligands from [Pt(bpy)(H2O)2]
2+ by three vicinal dioxime. 




From the temperature dependence of the k1 and k2 
values the activation parameters were calculated: 
ΔH1
≠









 (for L1H),  
ΔH1
≠









(for L2H) and ΔH1
≠









 (for L3H) respectively. 
There occurs the formation of five member ring 
structure of the product by the coordination of two 
nitrogen atoms of LH with the Pt(II) center. One 
nitrogen atom first attacks one of the Pt(II) centre by 
the removal of one water molecule (k1 path) and 
another nitrogen atom of the LH finishes the ring 
closing process (k2 path) by the removal of  
second water molecule. Based on the above 
experimental findings, we propose the following 
reaction mechanism (Fig. 6). 
 
Conclusions 
From a comparison of the ligands used, it can be 
concluded that the variation in bulkiness and 
electronic effect of the entering vicinal-dioximes 
reflects their properties as nucleophiles and their 
reactivity follows the order: L3H < L2H < L1H. The 
sensitivity of the reaction rate towards donor 
properties of the entering ligands are in the line with 
that expected for an associative mode of activation. 
Due to the highest steric effect, the reactivity of the 
ligand (L3H) was lowest which reflects in the rate 
constant values. The reactivity of the complexes 
follow the below trend: [Pt(bpy)(H2O)2](ClO4)2 >˃ 
[Pt(en)(H2O)2](ClO4)2 > [Pt(pipen)(H2O)2](ClO4)2. 
The above order was already expected on the basis 
of the pKa values (viz., the obvious influence of the 
diamine spectator ligands on the reactivity of the 
Pt(II) center). Addition of π-acceptors to the 
complex results in an increased reactivity of the 
Pt(II) center. The reactions with the Pt(pipen) 
complex were expected to be slower than that of 
Pt(en), as the Pt(II) center in Pt(pipen) is less 
electrophilic due to the positive inductive effect (i.e., 
+I effect) of the piperidine ring compared to that of 
ethylenediamine. Where as in case of Pt(bpy), where 
two pyridine rings are adjacent to each other, the 
rates increase significantly. This can be attributed to 
the stronger trans-effect of π-acceptors such as 
pyridine rings compared to the weak trans-effect of 
amines of the type NH2R. These findings are also 
reflected in the pKa values of the coordinated water 
molecules, since they decrease with an increasing 
number of pyridine rings. So higher the 
electrophilicity of the metal center, smaller is the 
activation enthalpy because of stabilization of 
transition state and hence the above order of 
reactivity has been observed. 
 
Supplementary Data 
Supplementary data associated with this article are 
available in the electronic form at 
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